AlphaFold predicted structure
ARHGAP31 · Q2M1Z3

Mean pLDDT
42.9/ 100
Very low
1,444 residues
Confidence breakdown
- Very high(≥ 90)12%
- Confident(70–90)3%
- Low(50–70)3%
- Very low(< 50)82%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
Rho GTPase activating protein 31
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Clefting
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownVACTERL-like phenotypes
Adams-Oliver syndrome
hypertensive disorder
cerebral palsy
urinary system disorder
response to vaccine
hereditary disease
celiac disease
Intellectual disability
systemic lupus erythematosus
autoimmune disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Rho GTPase-activating protein 31
Functions as a GTPase-activating protein (GAP) for RAC1 and CDC42. Required for cell spreading, polarized lamellipodia formation and cell migration
ARHGAP31 · Q2M1Z3

Mean pLDDT
42.9/ 100
Very low
1,444 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0